Literature DB >> 21965865

Hydroxyzine-induced acute generalized exanthematous pustulosis: an uncommon side effect of a common drug.

Sorna L Kumar1, Reena Rai.   

Abstract

Entities:  

Year:  2011        PMID: 21965865      PMCID: PMC3179020          DOI: 10.4103/0019-5154.84732

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


× No keyword cloud information.
Sir, Hydroxyzine is the first-generation antihistamine of the piperazine class. It is one of the commonly prescribed antihistamines. We report a case of acute generalized exanthematous pustulosis (AGEP) in a patient who was administered hydroxyzine. A 67-year-old male patient of stable plaque psoriasis involving less than 10% of body surface area was on treatment with topical steroid and was administered hydroxyzine 10 mg. The next day, he developed fever with multiple itchy discrete pustules over the trunk, back and extremities. He had no history of drug allergy in the past or insect bite. On examination, diffuse erythema with numerous 1-2 mm non-follicular pustules was present over the neck, limbs and trunk and axillae [Figure 1]. No pustules were seen over the psoriatic plaque. The scalp, palms, soles and mucous membranes were spared. Differential diagnoses of pustular psoriasis and AGEP were considered. Gram's stain of the pustule showed plenty of neutrophils. KOH mount was negative. Complete blood count revealed neutrophilia and raised erythrocyte sedimentation rate (ESR). Renal and liver function tests were normal. Biopsy from the pustule showed spongiosis with dense subcorneal neutrophilic infiltrate [Figure 2], apoptotic keratinocytes, and papillary dermal edema with perivascular inflammatory infiltrate composed of lymphocytes, eosinophils and neutrophils [Figure 3]. The eruption completely subsided within 3 days of stopping hydroxyzine. With this clinical feature and histopathological findings, diagnosis of AGEP secondary to hydroxyzine was made.
Figure 1

Diffuse erythema with numerous non-follicular pustules over the forearms

Figure 2

Spongiosis with dense subcorneal neutrophilic infiltrate (H and E, ×4)

Figure 3

Perivascular inflammatory infiltrate composed of lymphocytes, eosinophils and neutrophils (H and E, ×40)

Diffuse erythema with numerous non-follicular pustules over the forearms Spongiosis with dense subcorneal neutrophilic infiltrate (H and E, ×4) Perivascular inflammatory infiltrate composed of lymphocytes, eosinophils and neutrophils (H and E, ×40) Pustule is a major feature in several different dermatoses, and it may also occur as a manifestation of drug hypersensitivity. AGEP is an uncommon eruption characterized by acute, extensive formation of sterile pustules, fever and peripheral blood leukocytosis. It shares several clinical and histological features in common with pustular psoriasis.[1] Over 90% of cases of AGEP are thought to be provoked by medications. Drugs causing AGEP include Dexamethasone, Paracetamol and Doxycycline. The onset of AGEP is usually within 2 days of exposure to the responsible medication. It can be confused with generalized pustular psoriasis or subcorneal pustular dermatosis. Pustules resolve spontaneously within 4–10 days and are often followed by a characteristic postpustular pinpoint desquamation. AGEP is not a variant of pustular psoriasis[2] and the neutrophilic inflammation as a manifestation of AGEP is due to IL-8–producing T cells, and Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) which contributes to the recruitment of polymorphonuclear leucocytes (PMN) into the epidermis.[3] Tsai et al. have reported a similar case of hydroxyzine-induced acute generalized pustulosis[4] and this is the only published case report. Anaphylaxis with hydroxyzine has also been reported.[5] Other side effects of hydroxyzine include sedation, dizziness, disturbed coordination and blurred vision. We report this case because hydroxyzine which is a commonly used drug can produce an uncommon side effect.
  5 in total

1.  Anaphylactic reaction to hydroxyzine in an anesthetized patient.

Authors:  A Charles; F Lavaud; A Gallet; C Boulay-Malinovsky; P M Mertes; J M Malinovsky
Journal:  Eur Ann Allergy Clin Immunol       Date:  2009-08

2.  Hydroxyzine-induced acute generalized exanthematous pustulosis.

Authors:  Y-S Tsai; M-E Tu; Y-H Wu; Y-C Lin
Journal:  Br J Dermatol       Date:  2007-10-10       Impact factor: 9.302

3.  T-cell involvement in drug-induced acute generalized exanthematous pustulosis.

Authors:  M Britschgi; U C Steiner; S Schmid; J P Depta; G Senti; A Bircher; C Burkhart; N Yawalkar; W J Pichler
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR).

Authors:  A Sidoroff; A Dunant; C Viboud; S Halevy; J N Bouwes Bavinck; L Naldi; M Mockenhaupt; J-P Fagot; J-C Roujeau
Journal:  Br J Dermatol       Date:  2007-09-13       Impact factor: 9.302

5.  Diltiazem-induced acute generalised exanthematous pustulosis.

Authors:  S H Wakelin; M P James
Journal:  Clin Exp Dermatol       Date:  1995-07       Impact factor: 3.470

  5 in total
  3 in total

1.  Rare case of phenytoin induced acute generalized exanthematous pustulosis with cerebellar syndrome.

Authors:  Pravin U Shingade; Vaishali Wankhede; Pritam S Kataria; Nitin Sonone
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

2.  Acute Generalized Exanthematous Pustulosis Induced by Fexofenadine.

Authors:  Tanvi Gupta; Vijay K Garg; Rashmi Sarkar; Anjali Madan
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

Review 3.  Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.

Authors:  Enriqueta Vallejo-Yagüe; Adrian Martinez-De la Torre; Omar S Mohamad; Shweta Sabu; Andrea M Burden
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.